Skip to main content

Table 2 List of pathogenic and likely pathogenic variants identified

From: Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer

Gene Transcript

cDNA change

Protein change

Variant Type

Consequence

IARC

Sex

Age at diagnosis

Personal history (age)

Familial history (cases)

BRCA1

NM_007294

c.5468-1G > A

p.(?)

SNV

Splicing

C5

F

69

breast

(42, 55)

pancreas (1), breast (1), uterus (1)

BRCA2

NM_000059

c.6039del

p.(Val2014TyrfsTer26)

del

Frameshift

C5

M

63

none

breast (1), stomach (1), lung (1), brain (1)

BRCA2

NM_000059

c.8364G > A

c.8364G > A

SNV

Missense

C5

M

72

none

NA

BRCA2

NM_000059

c.1532_133insT

(p.Pro512ThrfsTer2)

ins

Frameshift

C5

M

61

none

lung (1), prostate (1)

ATM

NM_000051

c.3275C > A

p.(Ser1092*)

SNV

Nonsense

C5

M

44

NA

NA

ATM

NM_000051

c.4236 + 2 T > A

p.(?)

SNV

Splicing

C4

F

56

none

none

PALB2

NM_024675

c.2167_2168del

p.(Met723Valfs*21)

del

Frameshift

C5

F

44

none

breast (1), colon (1), head and neck (1)

RAD50

NM_005732

c.1636-1G > A

p.?

SNV

Splicing

C4

M

53

none

none

  1. M Male, F Female, IARC International Agency for Research on Cancer classification (C5: pathogenic; C4: likely pathogenic), SNV Single Nucleotide Variation, NA Not available